iShares JPX-Nikkei 400 ETFJPXN

The iShares JPX-Nikkei 400 ETF (JPXN) remains a paradox of modern finance: a fund marketed as a gateway to Japan’s innovation-driven future, yet anchored in a portfolio dominated by traditional industries. As of July 2026, the ETF holds 400 Japanese equities with a top-heavy concentration-its top 10 holdings, including Toyota and SoftBank Group, account for 42.3% of total assets. Despite BlackRock’s AI-themed marketing blitz, the fund’s SEC filings reveal no active thematic screen for artificial intelligence; its mandate simply mirrors the Nikkei 400 index, which includes companies as diverse as Japan Tobacco and Nintendo.

JPXN’s operational reality is equally unglamorous. With $1.2 billion in assets under management and a reported daily trading volume of 150,000 shares, the ETF exhibits moderate liquidity but trails cheaper alternatives tracking the same index. BlackRock’s official UK product page discloses that the fund is not eligible for Financial Services Compensation Scheme protection, a detail buried beneath layers of aspirational language about 'concentrated industry-leading research.' The fund’s 0.20% expense ratio ranks mid-tier among Japan equity ETFs, though its tracking error of 0.15%-as reported by Nasdaq’s ETF analytics-suggests execution challenges in replicating the benchmark.

Recent developments include a minor rebalancing in Q2 2026 that increased exposure to healthcare stocks by 1.2%, though this change went unannounced in public filings. The fund’s three-year trailing return of 4.8% annualized has lag the TOPIX index during periods of yen weakness, a risk not addressed in BlackRock’s investor communications. For all its marketing grandeur, JPXN’s value proposition hinges on its low-cost access to a static basket of Japanese equities-a reality far less thrilling than the AI-driven narrative sold to investors.